Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis.

NCT02362074 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02362074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02362074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis.
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
January 21, 2015
Completion date
March 6, 2020
Enrollment
401 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis